Mandate

Vinge has advised Nick’s in connection with 100 MUSD funding round

October 29, 2021

Vinge has advised the food-tech brand Nick’s, which offers sugar free ice cream and snacks, in connection with their largest funding round to date.

The Company raised USD 100 million in a funding round led by investment company Kinnevik. Temasek, Ambrosia Investments, Gullspång Invest, Peak Bridge, Capagro and Nicoya also participated in the funding round, alongside other existing shareholders.

The Nick’s brand was launched four years ago and is today present in 16 markets. On the US market alone, Nick’s products are available in appr. 6,700 stores. The new funding will primarily be used to strengthen Nick’s growth in Europe and North America.

Vinge’s team consisted of Daniel Rosvall, Maria Dahlin Kolvik, Jonathan Riddersholm and Ebba Nyberg.

 

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024